Beamtree Holdings Ltd · ASX:BMT
Beamtree — Corporate Update (May 2022)
11 slides from Beamtree's corporate update, May 17, 2022
Slide 1: Business update
Y oD) < 7) = e) ® co i) yp oO me} [ok =) wn n vo Cc n =) [aa) N N So aq > oO = N a
Slide 2: About us
Slide 3: The problems we solve
the problems we solve The best health services deliver value for money by reducing avoidable mortality, waste, length of stay, readmissions and cost of care. Complications are costly. One in nine patients who go to hospital suffer a complication, which costs Australian hospitals more than A$5 billio
Slide 4: How we create value: the Learning Health System
How we create value: the Learning Health System Driving continuous improvement by better access to healthcare information – towards safety, quality and efficiency. Beamtree Product Families Collect health Return knowledge to information the rules engine Coding and data Clinical decision quality assu
Slide 5: Product Focus - RippleDown
Product Focus - RippleDown RippleDown application examples: Traditional Application 1. RippleDown Diagnostics: Data inputs Patient Medications Vital Diagnostics Financial Clinical Decision Support (Expert and auditor) history signs • Creates efficient use of valuable expertise, making complex action
Slide 6: Beamtree products
Beamtree products Product Application Problem Solved ROI Pricing/Scale RippleDown Clinical rules to automate expert Removes duplication for experts in More value with less costly Expert decision making in Diagnostics providing diagnostic results resources Recurring License + Diagnostic volume based
Slide 7: Beamtree trading update - New Contract Wins
Beamtree trading update - New Contract Wins Going Forward: • Ampath five-year RippleDown® contract agreed: new long-term strategic partnership • ~30% of FY22 revenue • Lancet Laboratories two-year contract renewal: renewed its diagnostic technology contract • Focus on international relationship of 1
Slide 8: Supporting healthcare providers globally
Data as at June 2021 Supporting healthcare providers globally 50m+ people supported by Beamtree implementations every year 1000+ 155+ 705+ 4 23 140+ Hospitals Labs Hospitals Continents Countries Customers
Slide 9: Driving Beamtree's future growth
Driving Beamtree’s future growth Transformation Domestic TAM $427m, Innovation International TAM $13.6bn Expansion Domestic TAM $310m, • Goals and objectives focussed Domestic TAM $100m, International TAM $10.1bn entirely on future creative thinking International TAM $3.8bn • Transformative directio
Slide 10: Financial Summary 1H FY22
Financial Summary 1H FY22 Growth and investment was the focus for the first half of FY22, despite ongoing challenges presented by the COVID-19 pandemic. Thanks to strong revenue performance and excellent customer retention rates, we were able to make significant investments across the business withi
Slide 11: Important Notice and Disclaimer
Important Notice and Disclaimer The material in this presentation is general background information about Beamtree Holdings Limited (ASX:BMT) and is current at the date of the presentation, 15 February 2022. This presentation may contain statements that are, or may be deemed to be, forward looking s